Tumor Biology

, Volume 36, Issue 7, pp 5537–5541 | Cite as

RETRACTED ARTICLE: CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer

  • Yongqian Chen
  • Ye Tian
  • Zhengguo Ji
  • Zhi Liu
  • Donghao Shang
Research Article


Multiple studies have shown that CC-chemokine receptor 7 (CCR7) promotes cell proliferation in several human cancers. We investigated the expression and clinical significance of CCR7 in our large collection of prostate cancer (PCa) samples and explored its function on the proliferation and migration of PCa cells. In this study, the expression of CCR7 was examined by immunohistochemical staining and quantitative RT-PCR in primary PCa tissues from 60 patients who underwent radical prostatectomy. Then, we investigated the functional role of CCR7 in PCa cell proliferation and migration by small interfering RNA-mediated depletion. The positive rate of CCR7 staining was 88.33 % (53/60) in the PCa group and 16.67 % (10/60) in cases of benign prostate hyperplasia (BPH); the difference of CCR7 expression between PCa and BPH was statistically significant. The results were confirmed by quantitative real-time PCR. CCR7 was significantly elevated in all five PCa cell lines when compared to the RWPE-1 cells. Silencing of CCR7 inhibited the proliferation of PC3 cells which have a relatively high level of CCR7 in a time-dependent manner, and the invasion and migration of PC3 cells were distinctly suppressed. Our data suggest that the pathogenesis of human PCa maybe mediated by the CCR7, and thus CCR7 could represent selective targets for the molecularly targeted treatments of PCa.


Prostate cancer Chemokine receptors CCR7 Proliferation Migration Metastasis 


Conflicts of interest



  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Qu YY, Dai B, Kong YY, Ye DW, Yao XD, et al. Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl. 2013;15(1):110–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Sumida H, Yanagida K, Kita Y, Abe J, Matsushima K, Nakamura M, et al. Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis. J Immunol. 2014;192:4361–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Chiba F, Soda K, Yamada S, Tokutake Y, Chohnan S, Konishi F, et al. The importance of tissue environment surrounding the tumor on the development of cancer cachexia. Int J Oncol. 2014;44:177–86.PubMedGoogle Scholar
  5. 5.
    Maxwell PJ, Neisen J, Messenger J, Waugh DJ. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells. Oncotarget. 2014;5(13):4895–908.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Itakura M, Tokuda A, Kimura H, Nagai S, Yoneyama H, Onai N, et al. Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation. J Immunol. 2001;3:2071–9.CrossRefGoogle Scholar
  7. 7.
    Gao J, Wang A, Zhang M, Li H, Wang K, Han Y, et al. RNAi targeting of CCR2 gene expression induces apoptosis and inhibits the proliferation, migration, and invasion of PC-3 M cells. Oncol Res. 2013;21(2):73–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Shang ZJ, Liu K, Shao Z. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. Oral Oncol. 2009;45:480–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Wagner PL, Moo TA, Arora N, Liu YF, Zarnegar R, Scognamiglio T, et al. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol. 2008;15:2833–41.CrossRefPubMedGoogle Scholar
  10. 10.
    Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, KomotoI, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:3406–12.PubMedGoogle Scholar
  11. 11.
    Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol. 2005;79:3350–7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Tumour-immune cell interactions modulated by chemokines. Expert Opin Biol Ther. 2008;8:269–90.CrossRefPubMedGoogle Scholar
  13. 13.
    van den Bosch T, Koopmans AE, Vaarwater J, van den Berg M, de Klein A, Verdijk RM. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance. Invest Ophthalmol Vis Sci. 2013;54(12):7354–61.CrossRefPubMedGoogle Scholar
  14. 14.
    Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, et al. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 2000;60:2209–17.PubMedGoogle Scholar
  15. 15.
    Xu Y, Liu L, Qiu X, Jiang L, Huang B, Li H, et al. CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells. PLoS One. 2011;6(6):e21119.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ammirante M, Shalapour S, Kang Y, Jamieson CA, Karin M. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts. Proc Natl Acad Sci U S A. 2014;111(41):14776–81.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH, et al. Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxill oac Surg. 2010;48:291–6.CrossRefGoogle Scholar
  18. 18.
    Gollmer K, Asperti-Boursin F, Tanaka Y, Okkenhaug K, Vanhaesebroeck B, et al. CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood. 2009;114:580–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Liu FY, Safdar J, Li ZN, Fang QG, Zhang X, Xu ZF, Sun CF. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Int J Oncol. 2014 Sep 25.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Yongqian Chen
    • 1
  • Ye Tian
    • 1
  • Zhengguo Ji
    • 1
  • Zhi Liu
    • 1
  • Donghao Shang
    • 1
  1. 1.Department of Urology, Beijing Friendship HospitalCapital Medical UniversityBeijingChina

Personalised recommendations